Asia & Pacific

Magazine articles on conducting business in Asia and Pacific countries.

Old Articles: <Older 4081-4090 Newer>

Chemistry World December 4, 2013 Phillip Broadwith	Nike eliminates water at new Taiwanese dyeing plant Sports equipment giant Nike has opened a new fabric dyeing plant in Taiwan that uses a water-free dyeing method.
HBS Working Knowledge December 4, 2013 John Macomber	The Fantastic Horizon: How to Invest in a New City Rapid urbanization and resource scarcity pose problems -- and opportunities -- for businesses and governments all over the world. The author examines nascent privately-funded municipalities in Saudi Arabia and Vietnam.
Chemistry World November 12, 2013 Dinsa Sachan	Rough patch for India's clinical trial industry The Indian clinical trial industry is beset by uncertainty. Campaigners have petitioned the courts claiming that drug companies are exploiting poor people and this has led to more than 100 trials being put on hold.
Chemistry World November 8, 2013 Emily James	Japanese chemicals show signs of recovery The Japanese chemicals sector is showing signs of recovery, owing to reconstruction demand in the wake of the 2011 Tohoku earthquake and tsunami, as well as the government's bold new monetary and spending policies.
Pharmaceutical Executive November 1, 2013	Country Report: Taiwan The past three years have been some of the most eventful in memory for Taiwan's life sciences industry. At this year's Bio Taiwan exhibition, the excitement was palpable.
HBS Working Knowledge October 17, 2013 Carmen Nobel	Reserve Bank Governor Discusses India's Financial Opportunities A month after becoming the new governor of the Reserve Bank of India, Raghuram Rajan came to Harvard Business School to deliver the 2013 Leatherbee Lecture, "India: The Opportunities and Challenges Ahead."
On Wall Street September 1, 2013 Milton Ezrati	Can China's Economy Make a Soft Landing Predictions of a hard landing for this nation's economy are overblown.
Pharmaceutical Executive August 1, 2013 William Looney	Breaching the Great Wall With a revision of China's basic drug approval law now underway, a multinational team of experts is proposing major changes to make the country a world class player in innovation.
CIO July 30, 2013 John Ribeiro	Infosys Is Having Its Midlife Crisis Indian outsourcer Infosys -- in the midst of a major transformation -- struggles to supplement its commodity programming services with high-value business offerings
Pharmaceutical Executive March 1, 2013	China and the Emerging Markets Challenge: Why Big Pharma Must Embrace a New Strategy With health reform already tagged as a key domestic priority, their policies will pose new opportunities and challenges for Big Pharma companies active in China.
<Older 4081-4090 Newer> Return to current articles.